Avricore Health Inc Cash Flow Conversion Efficiency
Avricore Health Inc cash flow conversion efficiency. Based on the latest financial reports, Avricore Health Inc (AVCR) has a cash flow conversion efficiency ratio of -0.130x as of March 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CA$-25.44K ≈ $-18.40K USD) by net assets (CA$195.20K ≈ $141.21K USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Cash Flow Conversion Efficiency of Avricore Health Inc (2000–2025)
Cash flow conversion efficiency of Avricore Health Inc from 2000 to 2025. This chart illustrates how Avricore Health Inc's cash flow conversion efficiency has evolved over time, based on yearly financial data. View AVCR share price today for real-time trading data and today's change.
Avricore Health Inc Cash Flow Conversion Ratio Explained
Avricore Health Inc cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.
Avricore Health Inc Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Avricore Health Inc ranked by their cash flow conversion efficiency. Also see AVCR market cap overview for the company's overall valuation and market capitalisation.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
CAQ Holdings Ltd
AU:CAQ
|
-0.001x |
|
QX Resources Ltd
AU:QXR
|
-0.084x |
|
My Rewards International Ltd
AU:MRI
|
0.003x |
|
EMPYREAN ENERGY LS-002
F:E1E
|
N/A |
|
ROKMASTER Resources Corp
V:RKR
|
0.203x |
|
Reklaim Ltd
V:MYID
|
-0.299x |
|
Samfine Creation Holdings Group Limited
NASDAQ:SFHG
|
0.035x |
|
Lucapa Diamond Company Ltd
AU:LOM
|
-0.039x |
Annual Cash Flow Conversion Efficiency for Avricore Health Inc (2000–2025)
The table below shows the annual cash flow conversion efficiency of Avricore Health Inc from 2000 to 2025. Review Avricore Health Inc (AVCR) free cash flow to assess how much free cash flow the company generates relative to operating cash flow.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | CA$389.56K ≈ $281.80K |
CA$-789.93K ≈ $-571.43K |
-2.028x | -497.17% |
| 2024-12-31 | CA$1.97 Million ≈ $1.42 Million |
CA$1.00 Million ≈ $726.72K |
0.511x | +55.31% |
| 2023-12-31 | CA$2.01 Million ≈ $1.45 Million |
CA$660.40K ≈ $477.73K |
0.329x | +247.46% |
| 2022-12-31 | CA$1.96 Million ≈ $1.42 Million |
CA$-437.83K ≈ $-316.72K |
-0.223x | +60.32% |
| 2021-12-31 | CA$2.20 Million ≈ $1.59 Million |
CA$-1.23 Million ≈ $-892.77K |
-0.562x | -132.79% |
| 2020-12-31 | CA$-714.04K ≈ $-516.53K |
CA$-1.22 Million ≈ $-884.99K |
1.713x | +16.18% |
| 2019-12-31 | CA$-465.45K ≈ $-336.70K |
CA$-686.41K ≈ $-496.54K |
1.475x | +175.74% |
| 2018-12-31 | CA$885.97K ≈ $640.89K |
CA$-1.73 Million ≈ $-1.25 Million |
-1.947x | -175.22% |
| 2017-12-31 | CA$2.50 Million ≈ $1.81 Million |
CA$-1.77 Million ≈ $-1.28 Million |
-0.707x | +34.26% |
| 2016-12-31 | CA$1.92 Million ≈ $1.39 Million |
CA$-2.06 Million ≈ $-1.49 Million |
-1.076x | -81.28% |
| 2015-12-31 | CA$3.25 Million ≈ $2.35 Million |
CA$-1.93 Million ≈ $-1.39 Million |
-0.594x | -34.10% |
| 2014-12-31 | CA$3.35 Million ≈ $2.43 Million |
CA$-1.48 Million ≈ $-1.07 Million |
-0.443x | +45.59% |
| 2013-12-31 | CA$663.10K ≈ $479.67K |
CA$-539.52K ≈ $-390.28K |
-0.814x | -129.81% |
| 2012-12-31 | CA$436.69K ≈ $315.89K |
CA$-154.61K ≈ $-111.84K |
-0.354x | -897.35% |
| 2011-12-31 | CA$-1.32 Million ≈ $-955.71K |
CA$-58.66K ≈ $-42.44K |
0.044x | -92.97% |
| 2010-12-31 | CA$-1.07 Million ≈ $-771.49K |
CA$-673.34K ≈ $-487.08K |
0.631x | +104.18% |
| 2009-12-31 | CA$239.30K ≈ $173.10K |
CA$-3.61 Million ≈ $-2.61 Million |
-15.095x | -2699.35% |
| 2008-12-31 | CA$1.73 Million ≈ $1.25 Million |
CA$-930.62K ≈ $-673.20K |
-0.539x | -52.29% |
| 2007-12-31 | CA$2.48 Million ≈ $1.79 Million |
CA$-876.72K ≈ $-634.21K |
-0.354x | +25.57% |
| 2006-12-31 | CA$779.90K ≈ $564.17K |
CA$-371.02K ≈ $-268.39K |
-0.476x | +76.21% |
| 2005-12-31 | CA$157.37K ≈ $113.84K |
CA$-314.66K ≈ $-227.62K |
-1.999x | -33.90% |
| 2004-12-31 | CA$271.03K ≈ $196.06K |
CA$-404.72K ≈ $-292.77K |
-1.493x | -58.17% |
| 2003-12-31 | CA$800.22K ≈ $578.87K |
CA$-755.46K ≈ $-546.49K |
-0.944x | -1330.14% |
| 2002-12-31 | CA$182.98K ≈ $132.37K |
CA$14.04K ≈ $10.16K |
0.077x | +119.37% |
| 2001-12-31 | CA$184.42K ≈ $133.41K |
CA$-73.06K ≈ $-52.85K |
-0.396x | -202.19% |
| 2000-12-31 | CA$79.95K ≈ $57.83K |
CA$-10.48K ≈ $-7.58K |
-0.131x | -- |
About Avricore Health Inc
Avricore Health Inc. engages in the health data and point-of-care technologies businesses in Canada and the United Kingdom. It provides HealthTab, a turnkey point-of-care testing platform for pharmacies that can test up to 27 biomarkers on the spot for screening and managing chronic conditions, such as diabetes. The company was formerly known as Vanc Pharmaceuticals Inc. and changed its name to A… Read more